Raymond James Financial
CRL icon

Raymond James Financial’s Charles River Laboratories CRL Stock Holding History

Raymond James Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2M Buy
256,779
+63,247
+33% +$11.3M 0.02% 855
2026
Q1 		$33.4M Buy
193,532
+71,278
+58% +$13.2M 0.01% 1125
2025
Q4 		$24.4M Buy
122,254
+99,976
+449% +$18.1M 0.01% 1303
2025
Q3 		$3.49M Sell
22,278
-3,084
-12% -$490K ﹤0.01% 2738
2025
Q2 		$3.85M Sell
25,362
-197,597
-89% -$26.3M ﹤0.01% 2553
2025
Q1 		$33.6M Sell
222,959
-8,761
-4% -$1.47M 0.01% 956
2024
Q4 		$42.8M Buy
+231,720
New +$44.6M 0.02% 810

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Raymond James Financial's CRL Position: Q2 2026 in Review

Raymond James Financial increased its Charles River Laboratories (CRL) stake by 33% in Q2 2026, buying an estimated $11.3M and bringing the position to 256,779 shares worth $58.2M. The position accounts for 0.02% of the portfolio, ranked #855.

Raymond James Financial first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Raymond James Financial held 256,779 shares of Charles River Laboratories worth $58.2M as of Q2 2026.
  • Raymond James Financial bought 63,247 Charles River Laboratories shares in Q2 2026, an estimated $11.3M.
  • Charles River Laboratories made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #855 holding.
  • Raymond James Financial first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.